{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:21:03Z","timestamp":1789777263026,"version":"4.0.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Early detection of cancer predisposition syndromes (CPS) is crucial to determine optimal treatments and follow-up, and to provide appropriate genetic counseling. This study outlines an approach in a pediatric oncology unit, where 50 randomly selected patients underwent clinical assessment, leading to 44 eligible for genetic testing. We identified 2 pathogenic or likely pathogenic variants in genes associated with CPS and 6 variants of uncertain significance (VUS) potentially associated with cancer development. We emphasize the importance of a thorough and accurate collection of family history and physical examination data and the full coordination between pediatric oncologists and geneticists.<\/jats:p>","DOI":"10.1097\/mph.0000000000002932","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T07:04:54Z","timestamp":1730185494000},"page":"409-414","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Cancer Predisposition Syndromes in Children: Who, How, and When Should Genetic Studies Be Considered?"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1500-789X","authenticated-orcid":false,"given":"M\u00f3nica","family":"Camacho-Arias","sequence":"first","affiliation":[{"name":"Pediatric Oncology Unit, Health Research Institute HM Hospitals, HM Montepr\u00edncipe University Hospital\/CIOCC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Villa","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Health Research Institute HM Hospitals, HM Montepr\u00edncipe University Hospital\/CIOCC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"\u00c1lvarez de Andres","sequence":"additional","affiliation":[{"name":"Nimgenetics, Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara","family":"Rivera","sequence":"additional","affiliation":[{"name":"IDIBELL, Hereditary Cancer Programme, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"V\u00e1zquez","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Health Research Institute HM Hospitals, HM Montepr\u00edncipe University Hospital\/CIOCC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Let\u00f3n","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Health Research Institute HM Hospitals, HM Montepr\u00edncipe University Hospital\/CIOCC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7591-5473","authenticated-orcid":false,"given":"Laura","family":"Mart\u00edn-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Health Research Institute HM Hospitals, HM Montepr\u00edncipe University Hospital\/CIOCC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2169-9266","authenticated-orcid":false,"given":"Marta Pilar","family":"Osuna-Marco","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Health Research Institute HM Hospitals, HM Montepr\u00edncipe University Hospital\/CIOCC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"L\u00f3pez-Ibor","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Unit, Health Research Institute HM Hospitals, HM Montepr\u00edncipe University Hospital\/CIOCC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric cancer","volume":"373","author":"Zhang","year":"2015","journal-title":"N Engl J Med"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Gr\u00f6bner","year":"2018","journal-title":"Nature"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S2352-4642(20)30275-3","article-title":"Predisposition to cancer in children and adolescents","volume":"5","author":"Kratz","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"pkab007","DOI":"10.1093\/jncics\/pkab007","article-title":"Frequency of pathogenic germline variants in cancer-susceptibility genes in the childhood cancer survivor study","volume":"5","author":"Kim","year":"2021","journal-title":"JNCI Cancer Spectrum"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/jmedgenet-2018-105488","article-title":"Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature","volume":"55","author":"Sylvester","year":"2018","journal-title":"J Med Genet"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejca.2017.04.021","article-title":"Childhood tumours with a high probability of being part of a tumour predisposition syndrome; reason for referral for genetic consultation","volume":"80","author":"Postema","year":"2017","journal-title":"Eur J Cancer"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10689-021-00234-4","article-title":"Proportion of children with cancer that have an indication for genetic counseling and testing based on the cancer type irrespective of other features","volume":"20","author":"Minh","year":"2021","journal-title":"Fam Cancer"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1158\/1078-0432.CCR-17-0834","article-title":"Genetic counselor recommendations for cancer predisposition evaluation and surveillance in the pediatric oncology patient","volume":"23","author":"Druker","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.26718","article-title":"Consequences of diagnosing a tumor predisposition syndrome in children with cancer: a literature review","volume":"65","author":"Postema","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ajmg.a.38142","article-title":"Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology","volume":"173","author":"Ripperger","year":"2017","journal-title":"Am J Med Genet A"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10897-017-0077-8","article-title":"A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes","volume":"26","author":"Scollon","year":"2017","journal-title":"Journal of Genetic Counseling"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejmg.2016.01.008","article-title":"Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool","volume":"59","author":"Jongmans","year":"2016","journal-title":"Eur J Med Genet"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"e26441","DOI":"10.1002\/pbc.26441","article-title":"The McGill Interactive Pediatric OncoGenetic Guidelines: An approach to identifying pediatric oncology patients most likely to benefit from a genetic evaluation","volume":"64","author":"Goudie","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1200\/JCO.21.00018","article-title":"Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors","volume":"39","author":"Cullinan","year":"2021","journal-title":"J Clin Oncol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2021.4536","article-title":"Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes","volume":"7","author":"Goudie","year":"2021","journal-title":"JAMA Oncol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.3390\/cancers14153741","article-title":"Diagnostic strategies and algorithms for investigating cancer predisposition syndromes in children presenting with malignancy","volume":"14","author":"Rossini","year":"2022","journal-title":"Cancers"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10689-021-00237-1","article-title":"Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study","volume":"20","author":"Postema","year":"2021","journal-title":"Fam Cancer"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41431-021-00878-x","article-title":"Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer","volume":"29","author":"Wagener","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.3390\/cancers13215339","article-title":"Germline predisposition to pediatric cancer, from next generation sequencing to medical care","volume":"13","author":"Gargallo","year":"2021","journal-title":"Cancers"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s43018-021-00172-1","article-title":"Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors","volume":"2","author":"Fiala","year":"2021","journal-title":"Nat Cancer"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41525-018-0070-7","article-title":"Clinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours","volume":"3","author":"Chan","year":"2018","journal-title":"NPJ Genom Med"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"e1009231","DOI":"10.1371\/journal.pgen.1009231","article-title":"Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes","volume":"16","author":"Byrjalsen","year":"2020","journal-title":"PLoS Genetics"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.1016\/S1470-2045(21)00425-3","article-title":"Avoidance or adaptation of radiotherapy in patients with cancer with Li-Fraumeni and heritable TP53-related cancer syndromes","volume":"22","author":"Thariat","year":"2021","journal-title":"Lancet Oncol"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","article-title":"Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes","volume":"28","author":"Frebourg","year":"2020","journal-title":"Eur J Hum Genet"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2017.06.018","article-title":"Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome","volume":"403","author":"Westdorp","year":"2017","journal-title":"Cancer Lett"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:00:29Z","timestamp":1754337629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002932","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"2024-02-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}